Kasper, B., Rauch, G., Limprecht, R., Sommer, M., Dimitrakopoulou-Strauss, A., Pilz, L. R., & Hohenberger, P. (2017). Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). European journal of cancer, 76, . https://doi.org/10.1016/j.ejca.2017.02.001
Chicago-Zitierstil (17. Ausg.)Kasper, Bernd, Geraldine Rauch, Ronald Limprecht, Michaela Sommer, Antonia Dimitrakopoulou-Strauss, Lothar R. Pilz, und Peter Hohenberger. "Imatinib Induces Sustained Progression Arrest in RECIST Progressive Desmoid Tumours: Final Results of a Phase II Study of the German Interdisciplinary Sarcoma Group (GISG)." European Journal of Cancer 76 (2017). https://doi.org/10.1016/j.ejca.2017.02.001.
MLA-Zitierstil (9. Ausg.)Kasper, Bernd, et al. "Imatinib Induces Sustained Progression Arrest in RECIST Progressive Desmoid Tumours: Final Results of a Phase II Study of the German Interdisciplinary Sarcoma Group (GISG)." European Journal of Cancer, vol. 76, 2017, https://doi.org/10.1016/j.ejca.2017.02.001.